{"id":437925,"date":"2025-12-10T13:36:20","date_gmt":"2025-12-10T13:36:20","guid":{"rendered":"https:\/\/www.europesays.com\/us\/437925\/"},"modified":"2025-12-10T13:36:20","modified_gmt":"2025-12-10T13:36:20","slug":"promotional-labeling-and-advertising-considerations-for-prescription-b-fda-gov","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/437925\/","title":{"rendered":"Promotional Labeling and Advertising Considerations for Prescription B – fda.gov"},"content":{"rendered":"
    \n
  1. Promotional Labeling and Advertising Considerations for Prescription B<\/a>  fda.gov<\/li>\n
  2. Professor Sarfaraz K. Niazi Files Landmark Citizen Petition Urging the FDA to Modernize Biosimilar Approval Pathways and Transform Global Access to Biological Medicines<\/a>  Yahoo Finance<\/li>\n
  3. Biosimilars News Roundup: Approvals Surge Amid Policy Changes<\/a>  Center for Biosimilars<\/li>\n
  4. FDA\u2019s Drug Price Push in Biosimilar Plan Hinges on Other Reforms<\/a>  Bloomberg Law News<\/li>\n
  5. Is FDA Streamlining Regulations in the Biosimilar Space?<\/a>  Pharmaceutical Executive<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"Promotional Labeling and Advertising Considerations for Prescription B  fda.gov Professor Sarfaraz K. Niazi Files Landmark Citizen Petition Urging the…\n","protected":false},"author":3,"featured_media":231978,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[210,1060,67,132,68],"class_list":{"0":"post-437925","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-health","9":"tag-medication","10":"tag-united-states","11":"tag-unitedstates","12":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115695543016847769","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/437925","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=437925"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/437925\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/231978"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=437925"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=437925"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=437925"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}